Cavco Industries Reports Q3 Profit Decline Despite Revenue Growth, Backlog Shrinks

summarizeSummary

Cavco Industries reported an 11.3% increase in Q3 revenue but a 22.0% drop in net income and a 19.1% decline in diluted EPS, alongside a shrinking backlog. Nine-month results showed overall growth.

check_boxKey Events

• Q3 Profit Decline Despite Revenue Growth

  For the fiscal third quarter ended December 27, 2025, net revenue increased 11.3% to $581.0 million, but net income decreased 22.0% to $44.1 million, and diluted EPS fell 19.1% to $5.58 year-over-year.

• Nine-Month Financial Performance Shows Growth

  For the nine months ended December 27, 2025, net revenue grew 12.4% to $1.69 billion, net income increased 9.9% to $148.1 million, and diluted EPS rose 14.2% to $18.55.

• Backlog Decreases Significantly

  The company's backlog declined to $160 million as of December 27, 2025, down from $197 million at March 29, 2025, and $224 million at December 28, 2024.

• American Homestar Acquisition Details

  The acquisition of American Homestar Corporation on September 29, 2025, for $179.9 million, contributed $42.0 million in net revenue and $2.4 million in net income for the three months ended December 27, 2025.

auto_awesomeAnalysis

Cavco Industries' latest 10-Q filing reveals a mixed financial performance for the fiscal third quarter ended December 27, 2025. While net revenue increased by 11.3% to $581.0 million, net income saw a significant 22.0% decline to $44.1 million, and diluted EPS fell by 19.1% to $5.58 compared to the prior year. This profit contraction was primarily driven by higher costs per unit in the factory-built housing segment and increased selling, general, and administrative expenses, partly due to the American Homestar acquisition and related deal costs. Additionally, the company's backlog decreased to $160 million, indicating a softening in future orders. These factors suggest a challenging operating environment despite top-line growth. The full nine-month results, however, show overall growth in revenue, net income, and diluted EPS. The filing also details ongoing stock repurchases and routine 10b5-1 trading plans by the CFO and an independent director, which are minor in scope.